Sample output from the Growth Opportunity Analysis & Execution Plan prompt in the Sonar AI Prompt Library, run against a NetSuite test account. Every name and number here is test data. Back to the post · The library
Growth Strategy & Execution Plan
A data-driven strategic assessment of the multinational manufacturing group on NetSuite account TD3092577. v3 adds a per-subsidiary P&L — which materially changes the margin story and locates the management fee — plus two companion data exports (full backlog triage list, complete A/R aging by customer).
Prepared from live ERP data • August 9, 2026 • Senior Business Strategy Review • Print-ready (Ctrl/Cmd+P)
1.The Business at a Glance
A mid-market discrete manufacturer and distributor of electronic and industrial components — fan assemblies, flex circuit boards, hydraulic/vacuum pumps, solder materials, medical devices (portable ultrasound), and contract-manufactured goods. It runs a "make-in-Vietnam, sell-in-US" model: the Vietnam plant supplies the US distribution entity, with satellite subsidiaries in Canada, UK, Germany/Ireland, Japan, and Russia (several dormant; China already deactivated).
$20.7M
2026 GL revenue YTD
$7.1M
External revenue YTD (ex-IC)
44×
External monthly run-rate growth since Jan 2025
204
Active employees
467
Customer records (151 active buyers)
632
Inventory SKUs + 116 assemblies
External revenue by month (intercompany removed)
The real growth story: ~$25K/month in early 2025 → $1.1M/month in Aug 2026. GL headline figures are inflated by a ~$9.8M intercompany Vietnam→US transfer booked in May 2026 — excluded here.
External customer concentration (2025→YTD)
Top-5 external accounts ≈ 31% of external revenue — diversified for the size, no single account above ~12%.
Target audience / client base
B2B industrial OEMs & distributors — components (motors, PCBs, power cords) and assemblies, repeat orders on credit terms.
Contract-manufacturing clients — tolling, outside processing, and contract-MFG items are consistent top sellers.
Funnel shape: 467 customer records → only ~167 have ever been invoiced → 151 bought in 2026. The base is mostly ~300 never-activated prospects, not lapsed customers — an acquisition problem, not a churn problem.
2.Financial Health & Budget Reality
Top-line growth is real and steep. The consolidated P&L looks fragile — but the subsidiary view (§2b) shows the weakness is structural and intercompany, not commercial: the trading entities are healthy and profitable; the group result is dragged down by a $4.66M management fee booked in Vietnam.
35–36%
True GM at distribution entities
−$0.9M
2026 consolidated operating result
$1.30M
External A/R overdue (71% of open)
$3.25M
Order backlog awaiting fulfillment
$1.76M
Backlog stuck >90 days
Analyst's correction vs. v2: the consolidated "27.9% gross margin" reported earlier is not reliable. Vietnam's COGS accounts carry a ~$23.3M intercompany purchases credit (manufacturing/transfer postings), which pollutes any group-level COGS roll-up. Measured at the entity level, where the accounting is clean, the distribution subsidiaries earn ~35–36% gross margin and the flagship US entity substantially more. Margin repair (opportunity #5) remains valid but is re-aimed: the problem is not underpricing across the board — it is transfer-pricing structure and the management fee, plus selective SKU-level leaks.
Where the operating budget actually goes (2026 YTD)
Mgmt fees (in VN)
$4.66M
Salaries (G&A)
$587K
Rent
$325K
D&A
$313K
Commissions
$227K
Advertising
$85K ⚠
Budget insight — demand generation is starved: advertising is $85K (~1.2% of external revenue) vs. an industrial-peer norm of 1.5–3%. Meanwhile $4.66M flows out as management fees — the single biggest lever in the cost base. Reallocating even ~$150–200K into targeted demand gen is a 2.5× increase on today's spend, fundable entirely from A/R recovery.
External A/R aging (intercompany excluded) — $1.82M open
The bulge is 31–90 days — recoverable with normal collections pressure. Only $422K has aged past 90 days; ~$11K past a year. The separate $9.77M intercompany balance (66 days) needs a netting decision, not dunning. Full per-customer detail: ar-aging-by-customer.csv (§8).
Current
$520K
1–30 days
$71K
31–60 days
$521K
61–90 days
$287K
91–365 days
$411K
> 1 year
$11K
Fulfillment backlog aging — 691 open orders / $3.25M
125 orders (>$1.75M) unshipped for over 90 days against 3.7M units on hand — process, not stock. Oldest order (SO1806, Rhynyx Associates) is 395 days old. Full order-by-order triage list: backlog-triage-open-sales-orders.csv (§8).
0–30 days
325 orders
31–90 days
241 orders
91–180 days
92 orders
> 180 days
33 orders
2b.Per-Subsidiary P&L — Where the Money Is Actually Made
2026 YTD, posted GL, split by transaction-line subsidiary. This view resolves the consolidated puzzle: the trading entities are all profitable; the group loss lives in the Vietnam entity's management fee and HQ overhead.
Subsidiary
Revenue
COGS
Gross margin
Opex
Operating income
Read
United States
$7,581,244
$3,038,863
59.9%
$1,149,504
+$3,392,877
Profit engine
US-2
$1,926,809
$1,228,623
36.2%
$463,124
+$235,062
Healthy
United Kingdom
$751,389
$488,677
35.0%
$158,593
+$104,119
Healthy, small
Canada
$751,389
$489,777
34.8%
$170,370
+$91,242
Healthy, small
Headquarters
$5,523
—
—
$238,794
−$229,968
Corporate cost
Vietnam
$9,767,441 100% IC
distorted*
n/m
$4,651,164
n/m
Fee + transfer hub
Germany / Japan / Russia / Ireland
~$0
~$0
—
~$0
~$0
Dormant shells
*Vietnam's COGS accounts net to a ~$20.2M credit (a $23.3M intercompany "Purchases" credit less $3.0M finished-goods COGS) — manufacturing/transfer-pricing postings that only make sense post-elimination. Its revenue is 100% the intercompany sale to the US. Its $4.65M opex is almost entirely the group management fee ($4.66M account total).
Operating income by entity (2026 YTD, trading entities + HQ)
United States
+$3.39M
US-2
+$235K
United Kingdom
+$104K
Canada
+$91K
Headquarters
−$230K
VN mgmt fee
−$4.65M
Three strategic conclusions from the subsidiary view:
The commercial engine works. Trading entities produced ~$3.8M of combined operating income YTD at 35–60% gross margins. This is a fundamentally profitable business under a heavy group-fee structure.
The management fee is THE profitability lever. At $4.66M it exceeds all trading-entity profit combined. Renegotiating its basis (Phase 3) flips the consolidated result positive on its own.
UK and Canada are proven but tiny. Both run ~35% GM profitably at ~$750K revenue — the "commercialize vs. consolidate" question (Phase 4) now has an answer leaning commercialize: the model transplants; it just needs demand.
3.Challenges & Competitive Landscape
Internal challenges (from the data)
Cash $1.30M external A/R overdue + $9.77M intercompany unsettled; dunning configured but not enforced.
Funnel 117 estimates, zero tracked conversions; pipeline $118K vs. $13M+ external run-rate.
Activation ~300 customer records never purchased; only 16 genuinely lapsed buyers.
Quality 35 return authorizations ($120K) in 2026; an account literally named "Alpha Demand (Late Delivery)".
Geo Germany/Japan/Russia dormant; Russia carries geopolitical risk.
Competitive / market context
The ERP doesn't name competitors; product mix places the firm against these archetypes:
Global EMS/CM giants (Jabil, Flex, Sanmina) — win on scale. Counter: responsiveness, small batches, specialized assemblies.
Broadline distributors (Digi-Key, Mouser, Grainger-types) — win on availability & e-commerce. The 90-day backlog is a direct liability against them.
Regional Asian CMs — win on cost. The Vietnam hub keeps this firm competitive as buyers diversify from China (its own China entity is already inactive — consistent with the shift).
Structural advantages to press: Vietnam cost base + US inventory (3.7M units / 602 SKUs), serialized & warranty-tracked capability (medical), end-to-end make-to-order (work orders, BTO), and now-proven transplantability of the model to UK/Canada.
4.Growth Opportunities — Ranked by ROI × Difficulty
Ranked by expected 12-month cash/profit impact relative to effort. The subsidiary P&L promotes the management-fee renegotiation from a Phase-3 side item to a top-tier opportunity in its own right.
Demand generation investment — 0.4% → 1.5% of revenue, targeted at contract-MFG and medical-device niches; gated on #4
$1–2M pipeline (lagging)
Medium
★★★
8
Scale UK & Canada; rationalize the rest — both run 35% GM profitably at tiny scale; Germany/Japan dormant; Russia wind-down
$0.5–1.5M revenue
High
★★★
†Politically medium-to-hard — it is an intra-group negotiation, but the subsidiary P&L gives management the data to make the case.
OPPORTUNITY #1 — HIGHEST ROI
Cash Recovery Engine
Low difficulty30–60 day payback
The dunning module (levels, templates, procedures) is already configured — enforcement is the gap. The $1.30M overdue bulge sits at 31–90 days, the sweet spot where normal pressure recovers 70–85%. This cash funds every other initiative without external capital.
OPPORTUNITY #2
Backlog-to-Cash Sprint
Medium difficulty60–90 days
691 orders pending against 3.7M units on hand is a process constraint. Wave picking only went live May 2026 — the operation is mid-transition. The triage CSV (§8) classifies every order by age bucket, with >180-day orders pre-flagged for confirm-or-cancel.
OPPORTUNITY #3 — NEW IN V3
Management-Fee Restructuring
Medium difficultyFlips group P&L positive
The $4.66M fee booked in Vietnam exceeds the combined $3.8M operating profit of every trading entity. No commercial initiative on this list moves the consolidated bottom line as much as restructuring this single intra-group charge.
OPPORTUNITY #4
Funnel Instrumentation & Conversion
Medium difficultyGates #7
Zero of 117 estimates show linked orders — quotes die silently or reps bypass the record flow. Mandate estimate→SO transformation, a 48-hour quote SLA, and weekly pipeline review. Scaling demand gen into a leaky funnel wastes the budget.
5.12-Month Execution Roadmap
Phase 1 · Days 0–30 — "Stop the bleeding"
Cash & Credibility
A/R war room: assign owner; work the aging CSV top-down (Chatterpoint $255K/426d, Meetz $220K/92d, Rhynyx $152K/302d, Monrovia $120K, Abbott $106K/1,036d); activate dunning for everything 30+ days.
Reserve/write-off review for balances >365 days (Abbott, American Food $70K/945d).
Settle intercompany: clear the $9.77M Vietnam→US balance; set monthly netting cadence.
Backlog triage: work the triage CSV — stock-available / awaiting-build / blocked; confirm-or-cancel all 33 orders >180 days (starting with SO1806 at 395 days); ship everything pickable this month.
Credit policy: new-order credit holds for accounts >60 days past due.
Management-fee renegotiation: the headline event of this phase — restructure basis/timing or convert part to performance-linked. Success flips consolidated P&L positive on its own.
Demand-gen launch (~$150–200K, funded by recovered cash): position around Vietnam-based contract manufacturing + US stock availability; target electronics OEMs and medical-device firms diversifying from China. Hard gate: only if Phase-2 funnel instrumentation is live.
Key-account program for top 20 external customers (QBRs, forecast sharing, sell-side blanket orders — 7 blanket POs already prove the mechanism on the buy side).
Exit criteria fee restructured or escalated · $1M+ new qualified pipeline · 25+ newly activated accounts
Phase 4 · Days 181–365 — "Scale what works"
Expansion & Structure
Scale UK & Canada: both proven at ~35% GM — fund country plans (local rep, targeted demand gen, sell-side blankets) with a $1.5M combined revenue target for 2027.
Rationalize the rest: Germany/Ireland and Japan — commercialize with a concrete plan or consolidate; Russia — wind-down assessment given risk profile.
Contract-MFG productization: package tolling/outside-processing into marketed offerings with standard lead times.
Capacity planning: Vietnam plant loading and US warehouse capacity 2027 plan; inventory rationalization of the 3.7M-unit position (slow-mover cash release).
Companion data exports (delivered alongside this report)
backlog-triage-open-sales-orders.csv
All 691 open sales orders: order #, date, customer, status, value, age in days, age bucket (with "OVER 180 — CONFIRM OR CANCEL" pre-flagged), intercompany flag. Sorted oldest-first. This is the Phase-1 ops working document.
ar-aging-by-customer.csv
All 75 customers with open invoices: standard aging buckets (current / 1–30 / 31–60 / 61–90 / 91–365 / 365+), open invoice count, oldest days past due, intercompany flag. Sorted by total open descending. This is the collections war-room worksheet.
Next 11 actions (start Monday)
Interactive checklist — ticks persist in this browser via localStorage. 0 of 11 complete.
1. Distribute the A/R aging CSV, assign a collections owner, call the top 10 external debtorsCFO / AR lead · Wk 1
2. Activate the already-configured dunning procedures for invoices 30+ days past due (excl. top-20 white-glove)AR lead · Wk 1
3. Work the backlog triage CSV: ship-now / build-first / blocked; confirm-or-cancel all 33 orders >180 days (SO1806 first — 395 days)Ops lead · Wk 1
4. Book a reserve review with auditors for receivables >365 days (Abbott, American Food)Controller · Wk 2
5. Settle / net the $9.77M intercompany receivable; set monthly netting cadenceGroup finance · Wk 2
6. Ship every stock-available backlog order; stand up a daily shipped-vs-booked dashboardWarehouse mgr · Wks 2–4
7. Enforce estimate→SO transformation in NetSuite; add a 48h quote-response SLASales ops · Wk 3
8. Launch reactivation outreach to the 16 lapsed buyers (list below) + automated nurture for never-activated prospectsSales lead · Wk 4
9. Start the SKU-level pricing/margin review at entity levelProduct/Finance · Wks 3–6
10. Root-cause the 35 return authorizations; fix top 2 causesQuality lead · Wks 4–6
11. Assemble the management-fee evidence pack from the subsidiary P&L (§2b) and request the group negotiation slotCFO · Wks 4–8
Reactivation call list — lapsed buyers by lifetime value
Account
Lifetime revenue
Invoices
Last purchase
Zurasky Dynamics
$15,821
1
Sep 2025
Dabfeed Provisions
$12,552
3
Nov 2025
Cogilith inc.
$12,212
3
Aug 2025
Consectetuer Mauris Id LLP
$11,967
3
Oct 2025
Bark Less Dog Training
$9,025
4
Oct 2024
ABC Co.
$8,940
4
Jul 2024
Cogidoo Ltd.
$8,430
4
Jul 2025
Cogibox LP
$8,345
4
Jun 2025
Centimia LLp
$7,814
3
Feb 2025
Consectetuer Limited Ltd.
$4,501
3
Sep 2025
16 lapsed buyers total ($114K lifetime). Modest individually — the bigger prize is the ~300 never-activated prospect records and share-of-wallet growth in the 151 active accounts.
The strategic thesis, updated for v3: This company doesn't have a demand problem or a margin problem — external sales grew from ~$25K to $1.1M/month in 20 months, and every trading entity is profitable at 35–60% gross margin. It has an execution-and-structure problem: ~$4.5M of earned value is trapped in overdue receivables and unshipped orders, and a $4.66M management fee erases more profit than every commercial initiative combined could add. The flywheel: collect the cash (Phase 1) → fix throughput and the funnel (Phase 2) → restructure the fee and reinvest in demand (Phase 3) → scale the proven UK/Canada model (Phase 4). Each phase funds the next; no external capital required.